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-Reactive Protein in Acute Myocardial Infarction
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sunemori Sakamoto, MD,* Yukio Nishida, MD,* Takahiko Kawarabayashi, MD,* Daiju Fukuda, MD,†
unichi Yoshikawa, MD, FACC†
akai and Osaka, Japan
OBJECTIVES This study sought to investigate the relationship between multiple plaque ruptures, C-reactive
protein (CRP), and clinical prognosis in acute myocardial infarction (AMI).
BACKGROUND Several studies have demonstrated that ruptured or vulnerable plaques exist not only at the
culprit lesion but also in the whole coronary artery in some acute coronary syndrome (ACS)
patients. Recent studies have reported that a ruptured plaque at the culprit lesion is associated
with elevated CRP, which indicates a poor prognosis in patients with ACS.
METHODS We performed intravascular ultrasound in 45 infarct-related arteries and another 84 major
coronary arteries in 45 first AMI patients.
RESULTS Plaque rupture was observed in 21 patients (47%) at the culprit site. Intravascular ultrasound
revealed 17 additional plaque ruptures at remote sites in 11 patients (24%). Patients with
multiple risk factors were more frequently found in our multiple-plaque rupture patients
compared with single-plaque rupture or nonrupture patients (82% vs. 40% vs. 29%, p 0.01).
High-sensitive CRP levels had a positive correlation with the number of plaque ruptures (p
0.01). All culprit lesions were successfully treated by percutaneous coronary intervention.
Patients with multiple plaque rupture showed significantly poor prognosis compared with
others (p  0.01).
CONCLUSIONS Multiple plaque rupture is associated with systemic inflammation, and patients with multiple
plaque rupture can be expected to show a poor prognosis. Our results suggest that AMI
treatment should focus not only on stabilization of the culprit site but also a systemic
approach to systemic stabilization of the arteries. (J Am Coll Cardiol 2005;45:1594–9)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.01.053© 2005 by the American College of Cardiology Foundation
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(number of pathologic studies have suggested that plaque
upture and subsequent thrombosis are major causes of acute
oronary syndrome (ACS) (1). Some studies have docu-
ented that ruptured plaque and/or vulnerable plaque exists
ot only at the culprit lesion but also in a pan-coronary
rtery setting in ACS patients (2–4). We have recently
eported that pre-intervention intravascular ultrasound
IVUS) can identify lesion morphology, including the fea-
ures of plaque rupture, in acute myocardial infarction
AMI) (5–7) and that ruptured plaque at the culprit lesion
s associated with elevated C-reactive protein (CRP) (8).
See page 1600
levation of CRP levels is associated with a poor prognosis
nd is a predictor of future risk of AMI (9–15). To the best
f our knowledge, however, few studies have addressed the
elationship between multiple-plaque rupture, CRP, and
rognosis in AMI. In this study, our aim was to investigate
he relationship between multiple-plaque rupture, as ob-
erved under IVUS, CRP, and prognosis in AMI.
From the *Baba Memorial Hospital, Sakai; and †Department of Internal Medicine
nd Cardiology Graduate School of Medicine, Osaka City University, Osaka, Japan.t
Manuscript received August 24, 2004; revised manuscript received December 30,
004, accepted January 11, 2005.ETHODS
atient population. Between December 2002 and July
003, we attempted to perform IVUS in the entire coronary
rees of 45 patients with a first AMI (with or without
T-segment elevation). Infarct-related arteries were ob-
erved using IVUS before any percutaneous coronary inter-
ention (PCI) within 6 h from the onset of symptoms, and
he remaining coronary vasculature was examined within
ne month. No patients received any thrombolytic therapy.
iagnosis of AMI was done according to a consensus
ocument of the Joint European Society of Cardiology/
merican College of Cardiology Committee for the Redef-
nition of Myocardial Infarction (16). The infarct-related
rteries or culprit lesions were identified using a combina-
ion of electrocardiographic findings, left ventricular wall
otion abnormalities on echocardiography, scintigraphic
ndings, and angiographic findings. We excluded from our
opulation patients with coronary artery bypass failure (n 
) or subjects who required emergent coronary artery bypass
raft surgery (n  2), patients with subacute thrombosis or
estenosis after PCI (n 2), and patients in whom adequate
VUS images of the culprit site could not be obtained (n 
). Patients in whom the culprit lesion could not be
dentified by angiograms were also excluded (n  1). We
urther excluded patients with active inflammatory disease
n  1) and postoperative status (n  1). The protocol for
he study was approved by the ethics committee of the Baba
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May 17, 2005:1594–9 Multiple Plaque Rupture and CRPemorial Hospital. We also obtained written, informed
onsent from all participants before initial coronary
ngiography.
tudy protocol. First, blood samples were taken from a
eripheral vessel in the emergency room before the admin-
stration of any medical agents. In all patients, coronary
ngiography was performed using a 6-F Judkins-type cath-
ter via the femoral approach. All patients received an
ntravenous bolus injection of 10,000 IU heparin and
ntracoronary isosorbide dinitrate (2 mg) before angiogra-
hy. All patients were evaluated with pre-intervention
VUS. The IVUS catheter (3.2-F Ultra Cross, or Atlantis,
oston Scientific, Massachusetts) was carefully advanced
istal to the culprit lesion under fluoroscopic guidance. It
as then pulled back automatically from the distal portion
t 0.5 mm/s, facilitating observation of the lesion. The
VUS images were recorded on S-VHS videotape for
ff-line analysis. While pulling back the catheter, we man-
ally infused a contrast medium suitable for IVUS imaging
6), while carefully observing the lesion. Coronary angiog-
aphy and IVUS were performed again one month after
nset.
RP analysis. The blood samples were centrifuged, and
erum was removed and stored at 80°C until an assay
ould be performed. High-sensitivity C-reactive protein
hs-CRP) was analyzed using a commercially available
esting kit (N-Latex CRP II, Dade Behring Marburg
mbh, Marburg, Germany). Measurements of hs-CRP
ere repeated one month after the onset of AMI.
nalysis of IVUS images. The morphologic features de-
ected in our IVUS images were interpreted by two inde-
endent experienced observers (D.F. and K.S.) unfamiliar
ith the clinical data. Evaluation of lesion morphology and
ther measurements during IVUS were done according to
he American College of Cardiology Clinical Expert Con-
ensus Document on Standards for Acquisition, Measure-
ent and Reporting of Intravascular Ultrasound Studies
17). Fissure was defined as an abrupt, focal, superficial
reak in the linear continuity of the plaque, extending in a
adial direction. Dissection was defined as rupture of the
laque creating one or more neolumina. A lipid pool-like
mage was defined as a pooling of low-echoic material or
cholucent material covered with a high-echoic layer (7).
omputer planimetry (TapeMeasure, Indec Systems,
apitola, California) was used to measure the culprit lesion
ite, including the morphometric parameters and external
lastic membrane cross-sectional area (EEM-CSA). The
Abbreviations and Acronyms
ACS  acute coronary syndrome
AMI  acute myocardial infarction
hs-CRP  high-sensitivity C-reactive protein
IVUS  intravascular ultrasound
PCI  percutaneous coronary interventionncidence of lesion EEM-CSA larger than the proximal seference EEM-CSA was defined as positive remodeling.
e defined IVUS plaque rupture lesions as follows: 1)
esions with fissure/dissection; or 2) lesions without fissure/
issection but in which injection of saline or contrast
edium confirmed a communication between the plaque
nd coronary artery lumen (8).
ngiographic analysis. Coronary angiograms were re-
iewed separately by two independent observers (Y.N. and
.S.) unaware of the IVUS findings. Perfusion degree was
valuated according to Thrombolysis In Myocardial Infarc-
ion (TIMI) criteria (18), and collaterals were graded
ccording to the Rentrop classification (19), with good
ollateral flow defined as grade 2 or 3. Angiographic
hrombus was defined as a filling defect seen in multiple
rojections surrounded by contrast in the absence of calci-
cation and 10 mm in length. Definition of complex
esions were followed a previous report (20).
linical follow-up. The medication protocol was left to
he discretion of the individual cardiologist. All patients
ere reviewed monthly at the outpatient clinic of the Baba
emorial Hospital. Data were collected prospectively from
ospital charts. The primary end point was major cardiac
dverse events, defined as cardiac death, recurrent or new-
nset ACS, coronary artery bypass graft surgery, and target
esion revascularization.
tatistical analysis. Results are expressed as the mean
alue  SD for continuous variables. Qualitative data are
resented as numbers (%). Statistical analysis was done with
ommercially available software (StatView, SAS Institute,
ary, North Carolina). Continuous variables were com-
ared using the Student t test or analysis of variance.
cheffe’s method was used for multiple comparisons, and
he chi-square test for categorical data. The IVUS measure-
ents were done only at the culprit site in this study.
pearman’s rank correlation test was used in analysis for the
orrelation between numbers of plaque ruptures and serum
RP levels. Clinical outcomes in multiple-plaque rupture
atients, single-plaque rupture patients, and nonplaque
upture patients were examined by Kaplan-Meier curves and
he log-rank test. A p value 0.05 was considered statisti-
ally significant.
ESULTS
laque rupture identified by IVUS. Intravascular ultra-
ound was conducted in all 45 culprit coronary arteries and
he other 84 major coronary arteries without serious com-
lications. For simply anatomic reasons (four small vessels
r two tortuous arteries), IVUS could not be used success-
ully in six coronary arteries in six patients (13%). Plaque
upture was observed in 21 patients (47%) at the culprit site
n the acute phase of AMI. Intravascular ultrasound re-
ealed 17 occult plaque ruptures at remote sites in 11
atients (24%). These 11 patients also presented plaque
upture at the culprit site. Other plaque ruptures in remote
ites of the infarct-related artery were found in 6 (13%) of
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Multiple Plaque Rupture and CRP May 17, 2005:1594–9hese 11 patients. This means that multiple-plaque ruptures
ere found in 11 patients (multiple-plaque rupture group);
single-plaque rupture at the culprit site was found in 10
atients (single-plaque rupture group); and no plaque rup-
ures were found in 24 patients (nonplaque rupture group).
he other IVUS findings are summarized in Table 1. A
epresentative case of multiple-plaque rupture is shown in
igure 1.
atient characteristics and angiographic results. The pa-
ient characteristics for each group are summarized in Table
. Half of our patients presented with ST-segment elevation
I. Patients with multiple-plaque rupture had more of a
istory of diabetes mellitus or multiple coronary risk factors,
s compared with the single-plaque rupture or nonplaque
upture group. Angiographic results have been summarized
n Table 3. The multiple-plaque rupture group presented
ith more complex lesions in both the infarct-related artery
nd other coronary arteries, as compared with other groups.
o distal protection device was used in this study.
igure 1. A representative case of multiple plaque rupture. Plaque rupture
Table 1. Pre-Intervention Intravascular Ultraso
Multiple
Rupt
(n 
IVUS images
Eccentric 8 (7
Fissure/dissection 10 (9
Lipid pool-like image 6 (5
Superficial calcium 5 (4
Deep calcification 5 (4
Positive remodeling 5 (4
Distal reference EEM CSA (mm2) 15.3 
Distal reference lumen CSA (mm2) 7.2 
Lesion EEM CSA (mm2) 18.2 
Lesion lumen CSA (mm2) 2.2 
Proximal reference EEM CSA (mm2) 18.9 
Proximal reference lumen CSA (mm2) 8.9 
*p 0.01 vs. single-plaque rupture. †p 0.05 vs. others. The
Data are presented as the mean value  SD or number (%)
CSA  cross-sectional area; EEM  external elastic meo
ere observed in the proximal left descending coronary artery and mid
ortion of the right coronary artery.esults of CRP levels. Patients with plaque rupture at the
ulprit site presented with higher hs-CRP levels, as com-
ared with patients without plaque ruptures (3.1 0.5 mg/l
s. 1.9 0.4 mg/l, p 0.04). At one month from onset, the
umber of plaque ruptures showed a positive correlation
ith hs-CRP levels (p  0.01) (Fig. 2).
linical outcomes. The mean clinical follow-up period
as 23  11 months. During follow-up, all patients
eceived aspirin, 42 patients (93%) received ticlopidine, 9
atients (20%) received beta-blockers, and 11 patients
24%) received statins. There were no significant differences
n the use of these three drugs in the three groups. There
ere no cardiac events during the in-hospital period. After
ischarge, there was one death and four cases (8.9%) of
ecurrent ACS. All four patients were from the multiple-
laque rupture group (one case from a remote site in the
nfarct-related artery and three from a non–infarct-related
rtery), and no mortality or ACS was observed in other
roups. Repeat PCI at the culprit lesion was performed in
ne patient in the multiple-plaque rupture group, two in the
ingle-plaque rupture group, and two in the nonplaque
upture group. Therefore, a total of nine patients (20%) with
ecurrent ischemia required repeat PCI. The Kaplan-Meier
urve showed that the multiple-plaque rupture group was
ssociated with poor clinical outcomes, as compared with
he other groups at two years (p  0.01) (Fig. 3).
ISCUSSION
ultiple-plaque rupture, hs-CRP, and prognosis. Our
esults in this study demonstrate that some patients with
MI have multiple-plaque ruptures, which may be associ-
ted with systemic inflammation and adverse clinical out-
omes. These observations support the concept that plaque
nstability not only is a localized vascular event but also
eflects a more generalized inflammatory response through-
Findings of Culprit Lesions
ue Single-Plaque
Rupture
(n  10)
Nonplaque
Rupture
(n  24) p Value
8 (80%) 10 (42%) 0.06
6 (67%) 0
7 (70%) 0 0.001
5 (50%) 10 (42%) 0.9
2 (20%) 10 (42%) 0.41
3 (30%) 8 (33%) 0.72
17.3  6.1 12.7  4.0* 0.03
8.1  4.0 5.9  2.7 0.13
17.4  5.0 13.4  4.1† 0.02
2.5  2.1 2.0  2.1 0.59
20.5  5.7 14.8  4.6† 0.01
11.3  5.4 6.6  2.4* 0.01
lues resulted from Scheffe’s method of multiple comparisons.
ients.
e; IVUS  intravascular ultrasound.und
-Plaq
ure
11)
3%)
1%)
5%)
5%)
5%)
9%)
5.0
2.4
6.3
1.1
6.7
3.1
se p vaut the coronary tree.
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May 17, 2005:1594–9 Multiple Plaque Rupture and CRPWe have previously reported that the presence of rup-
ured plaque at the culprit site is only related to elevated
RP in patients with AMI (8). In this study, we again
ound that patients with plaque rupture at the culprit site
howed higher hs-CRP levels in the acute phase of AMI.
ecently, Hong et al. (21) also found an association between
levated CRP levels and the presence of plaque rupture in
heir own triple-vessel IVUS study. They concluded that an
levated CRP level is an independent clinical predictor of
laque rupture in AMI patients. Plaque rupture occurs most
requently at the point where the fibrous cap is thinnest and
ost heavily infiltrated by macrophage foam cells. These
upture-related macrophages are activated, which indicates
ngoing inflammation at the site of plaque disruption.
acrophages are capable of degrading the extracellular
atrix by the process of phagocytosis or by secreting
roteolytic enzymes, such as plasminogen activators and the
amily of matrix metalloproteinases that may weaken the
brous cap, thereby predisposing it to rupture (22).
Our results suggest that hs-CRP may reflect activity in
hese inflammation processes, leading to plaque rupture in
ll coronary arteries. Burke et al. (23) have reported that
RP may correlate with the number of thin-capped athe-
omas, which can be considered as vulnerable plaques, using
mmunohistochemical staining for CRP, in patients who
ad a sudden death associated with severe coronary artery
Table 2. Patient Characteristics
Multip
R
(n
Age (yrs) 66
Men 9
Coronary risk factors
Systemic hypertension 9
Diabetes mellitus 8
Smoking 7
Hypercholesterolemia (220 mg/dl) 5
Obesity (body mass index 25 kg/m2) 4
Risk factor 3 9
ST-segment elevation MI 6
Data are presented as the mean value  SD or number (%)
MI  myocardial infarction.
Table 3. Angiographic Findings
Multipl
Ru
(n 
Infarct-related artery
Left anterior descending artery 4 (3
Left circumflex artery 2 (1
Right coronary artery 5 (4
TIMI flow grade 0 on initial angiogram 5 (4
Good collateral flow 4 (3
Multivessel disease 5 (4
Complex lesions at remote site 9 (8
Final stent use 9 (8Data are presented as the mean value  SD or number (%) of pat
TIMI  Thrombolysis In Myocardial Infarction.isease. In an angiographic study, Zairis et al. (24) also
eported that CRP was associated with multiple complex
esions. We found that hs-CRP correlates directly with the
umber of plaque ruptures in the human body.
Furthermore, recent studies have suggested that CRP
ay play a direct role in promoting inflammatory athero-
clerosis (25,26). One recent study of a human CRP-
ransgenic mouse reported that human CRP may evoke
apid and frequent arterial thrombosis (27). Our results also
uggest CRP is not only a marker of systemic vascular
nflammation but also plays an important key role in plaque
isruption and subsequent thrombosis.
Our patients with multiple-plaque ruptures also pre-
ented more frequently with multiple risk factors. An
pidemiologic study reported that the extent of lesion
evelopment increases markedly with multiple coronary risk
actors in children and young adults (28). We speculate that
here were various systemic interactions over a long duration
ehind multiple-plaque ruptures.
Goldstein et al. (20) reported that multiple complex
laques, one of the angiographic features of plaque rupture
29), were associated with a poor prognosis. In their report,
ecurrent ACS and recurrent ischemia were observed in 9%
nd 24% of all patients, respectively, within one year. This
s very similar to our 8.9% and 20% rates. In this study,
atients with multiple-plaque ruptures also showed a sig-
laque
e
)
Single-Plaque
Rupture
(n  10)
Nonplaque
Rupture
(n  24) p Value
0 61  11 66  9.0 0.43
) 9 (90%) 18 (75%) 0.57
) 4 (40%) 12 (50%) 0.10
) 3 (30%) 6 (25%) 0.02
) 7 (70%) 14 (58%) 0.81
) 5 (50%) 10 (42%) 0.90
) 3 (30%) 3 (13%) 0.23
) 4 (40%) 7 (29%) 0.01
) 5 (50%) 13 (54%) 0.97
ients.
que Single-Plaque
Rupture
(n  10)
Nonplaque
Rupture
(n  24) p Value
4 (40%) 11 (46%) 0.97
2 (20%) 3 (13%)
4 (40%) 10 (42%)
4 (40%) 9 (38%) 0.77
2 (20%) 3 (13%) 0.26
3 (30%) 12 (50%) 0.56
1 (10%) 4 (17%) 0.01
10 (100%) 20 (83%) 0.37le-P
uptur
 11
 1
(82%
(82%
(73%
(64%
(45%
(36%
(82%
(55%e-Pla
pture
11)
6%)
8%)
5%)
5%)
6%)
5%)
2%)
2%)ients.
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Multiple Plaque Rupture and CRP May 17, 2005:1594–9ificantly poorer prognosis compared with others, as did all
f our recurrent ACS patients in the multiple-plaque
upture group. Our results may explain why hs-CRP has a
trong predictive value for cardiovascular events (30).
requency of multiple-plaque rupture. Previous IVUS
tudies have reported the frequency of multiple-plaque
upture in ACS, but the frequency of plaque rupture
eported is in sharp contrast. Rioufol et al. (3) reported that
ultiple-plaque ruptures were seen in 79% of all patients.
nother group recently reported that additional plaque
uptures were found in only 6% of patients in the infarct-
elated artery and 7% in the non–infarct-related artery (31).
otani et al. (4) reported that another plaque rupture was
ound in 15.8 % of cases in the infarct-related artery and
ultiple-plaque rupture in only 10.5% of patients, although
t should be stressed that they did not perform IVUS in all
igure 2. Relationship between the number of plaque ruptures and high
ensitivity C-reactive protein (hs-CRP) levels. At one month from onset,
he number of plaque ruptures showed a positive correlation with hs-CRP
evels (r  0.68, p  0.01).
igure 3. Event-free survival curve. The Kaplan-Meier curve showed that
he multiple-plaque rupture group was associated with poor clinical
utcomes as compared with the other groups at two years (p 0.01). Solidi
ine  multiple-plaque rupture; dashed line  single rupture; dotted
ine  nonrupture.oronary trees. Schoenhagen et al. (32) reported that 19% of
atients with AMI presented with other ruptured plaque in
he infarct-related artery. In our study, additional plaque
uptures at remote sites in the infarct-related arteries were
bserved in 13% of patients. We consider that this fre-
uency of additional plaque ruptures in infarct-related
rteries is similar to those of Kotani et al. (4) and Schoen-
agen et al. (32). One further piece of support comes from
he recent triple-vessel IVUS study by Hong et al. (21),
hich reported multiple-plaque rupture in 20% of AMI
atients, which is very similar to our own 24%.
The diagnosis of plaque rupture at the culprit site by IVUS
ay be strongly influenced by the presence, nature, and size of
coronary thrombus. We reported previously that thrombus
maging might be affected by the time from symptom onset to
maging (5). Low-echoic thrombus images that usually make
VUS assessments difficult increase in accordance with the
ime from symptom onset to imaging.
Rioufol et al. (3) used IVUS at 2.3  1.5 weeks after the
nset of ACS and Kotani et al. (4) at 4  2 days. In our
tudy, however, we did IVUS in the super-acute phase of
I. Furthermore, the use of adequate IVUS contrast is
ecessary to obtain good quality images. Another explana-
ion was patient selection. One of the inclusion criteria in
he Rioufol et al. (3) report was that all three epicardial
oronary arteries were suitable for IVUS. A coronary artery
uitable for IVUS is one without a bend and a large vessel.
ioufol et al. (3) also did not include patients in the acute
hase of AMI or in the critical stage of unstable angina. We
onsecutively enrolled AMI patients and tried to perform
VUS. Despite all this, 71% of patients presented with
ulti-vessel disease in the Rioufol et al. (3) study, but only 44%
n our study. A pathologic study suggested that healed plaque
upture might promote coronary stenosis (33). We therefore
peculated that the higher the number of stenotic lesions, the
reater association with more healed plaque ruptures.
tudy limitations. There is said to be a number of limita-
ions associated with the present study. The study popula-
ion was relatively small, and small or tortuous arteries were
ot explored by IVUS. Not all plaque-rupture cases may
resent with fissure/dissection, or plaques with communi-
ations to the lumen when observed under pre-intervention
VUS. Lesions with small, ruptured plaques may be misread
s nonruptured plaques. Our study may therefore contain
ome ruptured lesions misclassified as nonruptured lesions.
lso, an occluded artery is devoid of pressure and undergoes
lastic recoil with a marked reduction in all dimensional
easurements. Therefore, positive remodeling and its as-
essment can be substantially influenced by either the
resence of physiologic pressure in the artery or its absence.
ecause patients in this study had already presented with
laque rupture, it cannot be ascertained whether the CRP
levations are the result or the cause of the plaque rupture.
linical implications. Although a single lesion is clinically
ritical at the moment of ACS and is treated by catheter
ntervention, some patients have other plaque rupture or
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May 17, 2005:1594–9 Multiple Plaque Rupture and CRPuptures in remote sites and are associated with a poor
rognosis. We should therefore consider treatment and
trategy for ACS to be stabilization not only of the culprit
ite but also of the whole coronary tree by a systemic
pproach (i.e., multiple risk factor intervention) (34).
Statins were used in 24% of patients in this study.
ggressive systemic therapy might have reduced recurrent
vents. Also, there are some possibilities that local treat-
ents of one or two additional sites, in addition to the
ulprit site, might be needed, because systemic therapy is
ot all effective in reducing future events, and it might
equire several months to exert its beneficial effects. Al-
hough CRP is a nonspecific acute-phase reactant, our
esults may contribute to identifying high-risk patients in
he setting of AMI.
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